Table 1 |
|||||||
|
Clinical characteristics of patients at time of study and number of clonal viruses obtained |
|||||||
|
Patient |
Age/Sex |
Months since diagnosis |
Treatment* |
Viral Load (log10) |
CD4 T-cells (cells/μl) |
Number of clones |
Time to emergence of clones (days) |
|
|
|||||||
|
1 |
35/M |
17 |
none |
5.52 |
276 |
9 |
18 – 26 |
|
2 |
38/M |
26 |
none |
6.67 |
7 |
9 |
11 – 20 |
|
34 |
3TC ddI LPV # |
6.32 |
18 |
16 |
11 – 20 |
||
|
3 |
41/M |
210 |
none |
6.22 |
151 |
16 |
20 – 36 |
|
4 |
38/M |
114 |
3TC SQV/RTV |
5.43 |
11 |
12 |
14 – 27 |
|
5 |
40/M |
139 |
3TC ddI TDF TPV/RTV APV |
5.33 |
8 |
8 |
10 – 21 |
|
|
|||||||
|
*Abbreviations for antiretroviral drugs are as follows: amprenavir (APV), didanosine (ddI), lamivudine (3TC), ritonavir (RTV), saquinavir (SQV), tenofovir (TDF), tipranavir (TPV). #Poor compliance suspected. |
|||||||
|
Nora et al. Retrovirology 2008 5:23 doi:10.1186/1742-4690-5-23 |
|||||||